CORDIS - Forschungsergebnisse der EU
CORDIS

Regulation of Brain Macrophage Development and Function

Projektbeschreibung

Ein ganzheitlicher Blick auf Hirnmakrophagen

Mikroglia sind die häufigsten und langlebigsten angeborenen Immunzellen des zentralen Nervensystems. Sie bilden sich bereits früh in der Entwicklungsphase im Dottersack und haben die Hauptaufgabe, Krankheitserreger zu bekämpfen und Zelltrümmer zu beseitigen, um die Gewebehomöostase aufrechtzuerhalten. Das EU-finanzierte Projekt MADEFUN verfolgt das Ziel, zu beschreiben, wie die unterschiedlichen Makrophagenarten im Gehirn sich differenzieren und die Hirnentwicklung beeinträchtigen. Das Forschungsteam wird ihre räumlich-zeitliche Verteilung bestimmen und ferner die Beteiligung von Makrophagen an neuropathologischen Erkrankungen wie Neurodegeneration und Entzündung untersuchen.

Ziel

Macrophages are part of the mononuclear phagocyte system and play critical roles in innate immune responses. They further exert crucial organ-specific functions to warrant tissue homeostasis. Most macrophages are long-lived and derive from embryonic precursors. The central nervous system (CNS) contains several macrophage populations, of which microglia are the most prominent and abundant population residing in the CNS parenchyma. Besides being implicated in CNS pathologies, microglia guide neuronal development, are critical for neurogenesis and contribute to the maintenance of tissue homeostasis. At the interface between the brain and the periphery reside choroid plexus, perivascular and meningeal macrophages (‘border-associated’ macrophages, BAMs). While they mostly also originate from embryonic precursors, the differentiation cues and their specific roles in development and in health and disease are poorly understood. Here we will delineate the spatiotemporal emergence of BAMs and microglia, the impact of the local microenvironment on their phenotype and function, and their role in brain development. We will further analyze the role of BAMs and microglia in physiological and neuropathological conditions (neurodegeneration, CNS infection and inflammation). We have recently described a novel ‘microglia-specific’ conditional mouse and we are currently establishing an inducible system to specifically manipulate BAMs. We will use these to genetically intervene in different cytokine signaling pathways in combination with fate-mapping in vivo. The proposed research project will provide a deeper insight into microglia and BAM biology and their functional specializations at different stages of life.

Gastgebende Einrichtung

UNIVERSITAT ZURICH
Netto-EU-Beitrag
€ 1 995 500,00
Adresse
RAMISTRASSE 71
8006 Zurich
Schweiz

Auf der Karte ansehen

Region
Schweiz/Suisse/Svizzera Zürich Zürich
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
€ 1 995 500,00

Begünstigte (1)